BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 17168922)

  • 1. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
    Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
    Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
    Tan Y; Sinniah R; Bay BH; Singh G
    J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.
    Griffiths AP; Cross D; Kingston RE; Harkin P; Wells M; Quirke P
    Int J Gynecol Pathol; 1993 Oct; 12(4):307-14. PubMed ID: 8253547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AgNOR distribution in serous tumours of the ovary.
    Mauri FA; Scampini S; Aldovini D; Ferrero S; Barbareschi M; Dalla Palma P
    Pathologica; 1990; 82(1081):487-92. PubMed ID: 1706828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix.
    Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nucleolus organizer regions in pathomorphologic tumor diagnosis].
    Rüschoff J
    Veroff Pathol; 1992; 139():1-144. PubMed ID: 1413987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
    Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
    Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy.
    Lim SM; Duggan MA; Ruff M; Rahim S; McGregor SE; Green FH
    J Pathol; 1992 Jan; 166(1):53-60. PubMed ID: 1538274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
    Mohanty SK; Dey P; Rana P
    Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric analysis of AgNORs in the lymph node lesions.
    Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
    Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
    Zaczek M
    Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of AgNORs in serous ovarian tumors.
    Trabucco S; Varcaccio-Garofalo G; Botticella MA; De Stefano R; Capursi T; Resta L
    Eur J Gynaecol Oncol; 1994; 15(3):222-9. PubMed ID: 7525292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nucleolus organizers in the epithelium of serous ovarian tumors].
    Iakovtsova II
    Tsitol Genet; 1995; 29(5):38-41. PubMed ID: 8721844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.